Molecular Diagnostics files patent suit against Diamics

New York, Oct. 26 - Molecular Diagnostics, Inc. said it filed a suit against Diamics, Inc. and Diamics LLC alleging unfair business practices, misappropriation of its trade secrets and proprietary information, and patent and copyright infringement.

The Chicago-based company is seeking injunctive relief and damages of more than $30 million.

The suit, filed in the U.S. District Court for the Northern District of California, claims that Peter Gombrich, Molecular Diagnostics' former chairman and chief executive officer and the founder of Diamics, misappropriated Molecular Diagnostics' proprietary information, trade secrets and patented products.

Molecular Diagnostics is a biomolecular diagnostics company engaged in the design, development and commercialization of cost-effective screening systems to assist in the early detection of cancer.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.